Results 181 to 190 of about 4,863,726 (277)

Public Health Response to Imported Hansen's Disease Cases and Contact Investigation Findings in the Chungcheong Region, 2024-2025. [PDF]

Public Health Wkly Rep
Lee HY, Lee SD, Kim Y.
europepmc   +1 more source

Hansen's disease: (Week 37) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 16, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Hansen's disease cases.

core  

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

British Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown, Alan Armstrong, David J. Mann   +2 more
wiley   +1 more source

Lucio's Phenomenon in Hansen's Disease: A Case Report of a Condition Not to Be Forgotten. [PDF]

Cureus
Arenas Sanchez KA, Caicedo Vásquez PG, Sandoval Calle LM, Huertas JF, Vinueza JM.   +4 more
europepmc   +1 more source

Atypical Hansen's Disease Mimicking Xanthogranuloma: Role of Cytology. [PDF]

J Cutan Aesthet Surg, 2023
Vijayvergiya G, Panwar H, Santosh T, Patra S, Joshi D, Asati DP, Kapoor N.   +6 more
europepmc   +1 more source

Hansen's disease: (Week 24) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 1 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Hansen's disease cases.

core  

Leprosy mimicking basal cell carcinoma in a patient on fingolimod

JAAD Case Reports, 2017
Skylar Souyoul, MD, Katharine Saussy, MS, Barbara M. Stryjewska, MD, Elizabeth Grieshaber, MD   +3 more
doaj   +1 more source

Targeting protein–protein interactions with reversible covalent modalities: Non‐cysteine chemistries

British Journal of Pharmacology, EarlyView.
Abstract Protein–protein interactions (PPIs) are central to diverse cellular functions, and represent a rapidly expanding class of therapeutic targets. Advancements in covalent drug design have enabled small‐molecule drugs to overcome challenges associated with engaging these targets, such as limited durations of action and difficult‐to‐drug (expansive,
Ruchira Basu, Steven Fletcher
wiley   +1 more source

Hansen's disease: (Week 35) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 2, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Hansen's disease cases.

core  

Cancer pain: current practice and emerging targets

British Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye, Marcin Chwistek, Zhiting Gong, Vanessa Uzonwanne, Xiaojie Shi, Arpad Szallasi   +5 more
wiley   +1 more source